Citigroup’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86K Buy
4,747
+1,130
+31% +$20.5K ﹤0.01% 3757
2025
Q1
$74K Sell
3,617
-1,043
-22% -$21.4K ﹤0.01% 3982
2024
Q4
$120K Buy
+4,660
New +$120K ﹤0.01% 3906